[1] MATTIUZZI C,LIPPI G.Current cancer epidemiology[J].Journal of Epidemiology and Global Health,2019,9(4):217.
[2] SCHABATH MB,COTE ML.Cancer progress and priorities:Lung cancer[J].Cancer Epidemiol Biomarkers Prev,2019,28(10):1563-1579.
[3] HUTCHINSON BD,SHROFF GS,TRUONG MT,et al.Spectrum of lung adenocarcinoma[J].Semin Ultrasound CT MR,2019,40(3):255-264.
[4] DUMA N,SANTANA-DAVILAR,MOLINA JR.Non-small cell lung cancer:Epidemiology,screening,diagnosis,and treatment[J].Mayo Clinic Proceedings,2019,94(8):1623-1640.
[5] NOORELDEEN R,BACH H.Current and future development in lung cancer diagnosis[J].International Journal of Molecular Sciences,2021,22(16):8661.
[6] ALEXANDER M,KIM SY,CHENG H.Update 2020:Management of non-small cell lung cancer[J].Lung,2020,198(6):897-907.
[7] HIRSCH FR,SCAGLIOTTI GV,MULSHINE JL,et al.Lung cancer:current therapies and new targeted treatments[J].The Lancet,2017,389(10066):299-311.
[8] CHI Y,WANG D,WANG J,et al.Long non-coding RNA in the pathogenesis of cancers[J]Cells,2019,8(9):1015.
[9] BRIDGES MC,DAULAGALAAC,KOURTIDIS A.LNCcation:lncRNA localization and function[J].Journal of Cell Biology,2021,220(2):e202009045.
[10] PENG WX,KOIRALA P,MO YY.LncRNA-mediated regulation of cell signaling in cancer[J].Oncogene,2017,36(41):5661-5667.
[11] HU G,NIU F,HUMBURG BA,et al.Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis[J].Oncotarget,2018,9(26):18648-18663.
[12] DENG L,WANG P,QU Z,et al.The construction and analysis of ceRNA network and immune infiltration in kidney renal clear cell carcinoma[J].Frontiers in Genetics,2021,12:667610.
[13] DENISENKO TV,BUDKEVICH IN,ZHIVOTOVSKY B.Cell death-based treatment of lung adenocarcinoma[J].Cell Death & Disease,2018,9(2):117.
[14] YU P,HE X,LU F,et al.Research progress regarding long-chain non-coding RNA in lung cancer:a narrative review[J].Journal of Thoracic Disease,2022,14(8):3016-3029.
[15] 徐白雪,王维,庞敏,等.lncRNA RP11-297P16.4促进肺腺癌细胞侵袭及迁移的机制探讨[J].现代肿瘤医学,2023,31(03):395-401.
XU Baixue,WANG Wei,PANG Min,et al.Mechanism of lncRNA RP11-297P16.4 promoting invasion and migration of lung adenocarcinoma cells[J].Modern Oncology,2023,31(03):395-401.
[16] 谢飞,王朝霞.lncRNA 00628通过TOP2A影响肺腺癌细胞顺铂敏感性[J].现代肿瘤医学,2024,32(02):197-205.
XIE Fei,WANG Zhaoxia.Long non-coding RNA 00628 affects cisplatin sensitivity of lung adenocarcinoma cells by TOP2A[J].Modern Oncology,2024,32(02):197-205.
[17] WANG ZB,QU J,XIE P,et al.Integrative analysis of expression profile indicates the ECM receptor and LTP dysfunction in the glioma-related epilepsy[J].BMC Genomics,2022,23(1):430.
[18] ZHOU X,CHANG LS,LIANG QQ,et al.The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894[J].Cancer Cell Int,2024,24(1):47.
[19] ZHOU Q,LI D,ZHENG H,et al.A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma[J].Thoracic Cancer,2021,12(19):2526-2536.
[20] ZHANG X,WANG M,SUN H,et al.Downregulation of LINC00894-002 contributes to tamoxifen resistance by enhancing the TGF-beta signaling pathway[J].Biochemistry (Mosc),2018,83(5):603-611.
[21] CHEN B,LIU D,CHEN R,et al.Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression[J].Discover Oncology,2022,13(1):56.